Trastuzumab Recruiting Phase 3 Trials for Metastatic Breast Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0030200 (Metastatic Breast Cancer)	Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT02344472	Detect V / CHEVENDO (Chemo vs. Endo)	Trastuzumab (DB00072) Paclitaxel (DB01229) Ribociclib (DB11730) Fulvestrant (DB00947) Goserelin (DB00014) Exemestane (DB00990) Eribulin (DB08871) Letrozole (DB01006) Pertuzumab (DB06366) Docetaxel (DB01248) Leuprolide (DB00007) Capecitabine (DB01101) Anastrozole (DB01217) Vinorelbine (DB00361)
NCT03262935	SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer	Trastuzumab (DB00072) Lapatinib (DB01259) Capecitabine (DB01101) Eribulin (DB08871) Vinorelbine (DB00361)